Hanan S. Anbar

830 total citations
45 papers, 605 citations indexed

About

Hanan S. Anbar is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Hanan S. Anbar has authored 45 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Organic Chemistry and 7 papers in Oncology. Recurrent topics in Hanan S. Anbar's work include Synthesis and biological activity (9 papers), Enzyme function and inhibition (7 papers) and Melanoma and MAPK Pathways (6 papers). Hanan S. Anbar is often cited by papers focused on Synthesis and biological activity (9 papers), Enzyme function and inhibition (7 papers) and Melanoma and MAPK Pathways (6 papers). Hanan S. Anbar collaborates with scholars based in Egypt, United Arab Emirates and Pakistan. Hanan S. Anbar's co-authors include Mohammed I. El–Gamal, Mohammed I. El‐Gamal, Seyed–Omar Zaraei, Chang‐Hyun Oh, Hamadeh Tarazi, Sumera Zaib, Jamshed Iqbal, Saif Ullah, Jean Sévigny and Kyung Ho Yoo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Molecules.

In The Last Decade

Hanan S. Anbar

44 papers receiving 597 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanan S. Anbar Egypt 16 272 224 105 69 49 45 605
Huanqiu Li China 17 391 1.4× 116 0.5× 77 0.7× 74 1.1× 33 0.7× 40 690
Tonika Bohnert United States 9 228 0.8× 94 0.4× 138 1.3× 62 0.9× 77 1.6× 9 558
Jinhong Feng China 18 471 1.7× 239 1.1× 152 1.4× 55 0.8× 43 0.9× 52 818
Yuan Qing Qu Macao 14 284 1.0× 83 0.4× 94 0.9× 33 0.5× 31 0.6× 20 491
Kenichiro Doi Japan 15 560 2.1× 181 0.8× 160 1.5× 66 1.0× 34 0.7× 36 791
Wenwei Lin United States 23 645 2.4× 101 0.5× 348 3.3× 93 1.3× 51 1.0× 61 1.4k
Xiangrui Jiang China 16 475 1.7× 242 1.1× 74 0.7× 88 1.3× 182 3.7× 79 1.0k
Iwao Yamada Japan 13 235 0.9× 90 0.4× 220 2.1× 103 1.5× 67 1.4× 18 691
Renaud Warin United States 12 427 1.6× 74 0.3× 123 1.2× 90 1.3× 22 0.4× 18 854

Countries citing papers authored by Hanan S. Anbar

Since Specialization
Citations

This map shows the geographic impact of Hanan S. Anbar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanan S. Anbar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanan S. Anbar more than expected).

Fields of papers citing papers by Hanan S. Anbar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanan S. Anbar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanan S. Anbar. The network helps show where Hanan S. Anbar may publish in the future.

Co-authorship network of co-authors of Hanan S. Anbar

This figure shows the co-authorship network connecting the top 25 collaborators of Hanan S. Anbar. A scholar is included among the top collaborators of Hanan S. Anbar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanan S. Anbar. Hanan S. Anbar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Anbar, Hanan S., et al.. (2024). The wound healing and hypoglycemic activates of date palm (Phoenix dactylifera) leaf extract and saponins in diabetic and normal rats. PLoS ONE. 19(9). e0308879–e0308879. 2 indexed citations
3.
Jairoun, Ammar Abdulrahman, et al.. (2023). Over-the-counter antibiotic dispensing: knowledge and practice of community pharmacists in the United Arab Emirates. Journal of Pharmaceutical Health Services Research. 14(3). 333–342. 2 indexed citations
4.
Anbar, Hanan S., George S.G. Shehatou, Mona Abdel Rahim, Ghada M. Suddеk, & Nariman M. Gameil. (2023). Evaluation of regression of diabetes-induced nephropathy and vascular dysfunction in rats by Montelukast via antioxidative and anti-inflammatory actions. Journal of Applied Pharmaceutical Science. 2 indexed citations
5.
Anbar, Hanan S., Tamanna Islam, Fatema Hersi, et al.. (2023). Promising drug candidates for the treatment of polycystic ovary syndrome (PCOS) as alternatives to the classical medication metformin. European Journal of Pharmacology. 960. 176119–176119. 6 indexed citations
6.
Siddiqui, Ruqaiyyah, Mutasem Rawas‐Qalaji, Mohammed I. El–Gamal, et al.. (2023). Novel Anti-Acanthamoebic Activities of Irosustat and STX140 and Their Nanoformulations. Antibiotics. 12(3). 561–561. 5 indexed citations
7.
Sebastian, Anusha, Vunnam Srinivasulu, Hamadeh Tarazi, et al.. (2022). Design, synthesis, and biological evaluation of a new series of pyrazole derivatives: Discovery of potent and selective JNK3 kinase inhibitors. Bioorganic & Medicinal Chemistry. 69. 116894–116894. 9 indexed citations
8.
Zaraei, Seyed–Omar, Saif Ullah, Hanan S. Anbar, et al.. (2022). Design and synthesis of new adamantyl derivatives as promising antiproliferative agents. European Journal of Medicinal Chemistry. 246. 114958–114958. 7 indexed citations
9.
El–Gamal, Mohammed I., et al.. (2021). A Review of HER4 (ErbB4) Kinase, Its Impact on Cancer, and Its Inhibitors. Molecules. 26(23). 7376–7376. 38 indexed citations
10.
Anbar, Hanan S., et al.. (2021). Current status and future prospects of p38α/MAPK14 kinase and its inhibitors. European Journal of Medicinal Chemistry. 213. 113216–113216. 78 indexed citations
11.
Zaib, Sumera, et al.. (2021). Discovery of urease inhibitory effect of sulfamate derivatives: Biological and computational studies. Bioorganic Chemistry. 119. 105545–105545. 15 indexed citations
12.
El‐Gamal, Mohammed I., Seyed–Omar Zaraei, Paul Foster, et al.. (2020). A new series of aryl sulfamate derivatives: Design, synthesis, and biological evaluation. Bioorganic & Medicinal Chemistry. 28(8). 115406–115406. 16 indexed citations
13.
Zaraei, Seyed–Omar, Mohammed I. El–Gamal, Hanan S. Anbar, et al.. (2020). Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells. European Journal of Medicinal Chemistry. 210. 113081–113081. 17 indexed citations
14.
Zaraei, Seyed–Omar, et al.. (2019). Sulfamates in drug design and discovery: Pre-clinical and clinical investigations. European Journal of Medicinal Chemistry. 179. 257–271. 26 indexed citations
15.
Abduelkarem, Abduelmula R., et al.. (2019). Diarylamides in anticancer drug discovery: A review of pre-clinical and clinical investigations. European Journal of Medicinal Chemistry. 188. 112029–112029. 8 indexed citations
16.
Zaraei, Seyed–Omar, Mohammed I. El‐Gamal, Zainab Shafique, et al.. (2019). Sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as potent carbonic anhydrase II/IX/XII inhibitors. Bioorganic & Medicinal Chemistry. 27(17). 3889–3901. 12 indexed citations
17.
El–Gamal, Mohammed I., Hanan S. Anbar, Hamadeh Tarazi, & Chang‐Hyun Oh. (2019). Discovery of a potent p38α/MAPK14 kinase inhibitor: Synthesis, in vitro/in vivo biological evaluation, and docking studies. European Journal of Medicinal Chemistry. 183. 111684–111684. 11 indexed citations
18.
Anbar, Hanan S., George S.G. Shehatou, Ghada M. Suddеk, & Nariman M. Gameil. (2016). Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 780. 82–92. 22 indexed citations
19.
El‐Gamal, Mohammed I., Hanan S. Anbar, Kyung Ho Yoo, & Chang‐Hyun Oh. (2012). FMS Kinase Inhibitors: Current Status and Future Prospects. Medicinal Research Reviews. 33(3). 599–636. 33 indexed citations
20.
El‐Gamal, Mohammed I., Hanan S. Anbar, Hye Jin Chung, et al.. (2011). Design, synthesis, bioconversion, and pharmacokinetics evaluation of new ester prodrugs of olmesartan. European Journal of Medicinal Chemistry. 46(9). 3564–3569. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huanqiu Li Breakdown of academic impact, for papers by Tonika Bohnert Breakdown of academic impact, for papers by Jinhong Feng Breakdown of academic impact, for papers by Yuan Qing Qu Breakdown of academic impact, for papers by Kenichiro Doi Breakdown of academic impact, for papers by Wenwei Lin Breakdown of academic impact, for papers by Xiangrui Jiang Breakdown of academic impact, for papers by Iwao Yamada Breakdown of academic impact, for papers by Renaud Warin
Rankless by CCL
2026